This matters because GLP-1 therapy involves metabolic, cardiovascular, and gastrointestinal considerations that deserve thorough screening
What the Science Says About GHKCu and Hair Health Scientific investigations suggest that GHK-Cu stimulates hair follicles and supports robust hair growth
CMS requires providers to confirm the medication is used for weight reduction along with ongoing lifestyle changes, and that the individual met one of the following when treatment started: BMI 35 BMI 30 with conditions like HFpEF, uncontrolled hypertension, or CKD (stage 3a+) BMI 27 with prediabetes or established cardiovascular disease (e.g., prior MI, stroke, PAD) One important note: this coverage will operate outside of typical Part D plans, so the approval process will look different
Access and cost in the UK NHS access to Wegovy is limited
There is so much stigma out there around weight and an unfair paradigm that its about self-control or lack thereof, but the fact that these medications even work to empower women in their weight loss journey shows us that its about biologywith support of their biology, women can do it
